Neo-adjuvant immunotherapy emerges as best medical practice, and will be the new standard of care for macroscopic stage III melanoma
Alexander C. J. van Akkooi, Christian U. Blank, Alexander M.M. Eggermont
Topics & Concepts
MedicineNivolumabIpilimumabPembrolizumabAdjuvantOncologyAdjuvant therapyInternal medicineMelanomaImmunotherapyClinical trialLymph nodeNeoadjuvant therapyCancerCancer researchBreast cancerCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy research